Skip to Primary Navigation Skip to Site Navigation Skip to Main Content All Site Map

Microneedle Drug Delivery Systems

Increasing commercial success with patient-friendly solutions

Have an Expert in Your Corner

Hollow Microneedle Technology
3M hollow microstructured transdermal system (hMTS) offers a patient-friendly intradermal delivery solution for difficult to deliver biologics. Differentiate your product with an innovative hollow microneedle technology based on the latest human factors testing and voice-of-customer research.

The 3M hollow microstructured transdermal system (hMTS) delivers liquid formulations of 0.5 mL to 2 mL over a range of viscosities. In addition to the 3M hMTS kit for human factors studies, a preclinical device is now available. Inquire today.

Content Divide

3M™ Solid Microstructured Transdermal SystemSolid Microneedle Technology
Easy to use and patient friendly, solid microneedle patches provide transdermal drug delivery with up to 0.5 mg capacity, an efficiency that may match or exceed that provided by injection.

Content Divide

Related Posters, Presentations and Publications

3M Hollow Microneedle System Brochure (249 kb, PDF)

Hollow Microneedle Delivery - Innovation Pointing the Way (1,181 kb, PDF)

3M Drug Delivery Systems - Intradermal Delivery of Biologics

Patient Demand, Vaccines, And Drug Delivery: Q&A With Steve Wick Of 3M Drug Delivery Systems

3M Hollow Microstructured Transdermal System Human Factors Kit (727 kb, PDF)

Transdermal Development & Manufacturing Services from Start to Finish (video)

Microneedles as a Transformative Technology in Drug Delivery (998 kb, PDF)

Development of Lidocaine Coated Microneedle Product for Rapid Local Analgesic Action (570 kb, PDF)

POSTER: Microneedle Enabled Intradermal Delivery of Biologics (776 kb, PDF)

The 3M Microstructured Transdermal System (MTS) White Paper (2.46 mb, PDF)


Looking for the right drug delivery partner? Look to 3M.
Contact us for details today >>


3M provides you with the start to finish services you need to develop and commercialize your innovation.
Development & Commercialization

Patient Centered Innovation

Human factor research considerations for intradermal drug delivery.
Listen to the podcast

Commercialization services from 3M

Follow Us

linkedin icon image Youtube icon image